Abstract
A pre-exposure prophylaxis (PrEP) is indicated for populations vulnerable to human immunodeficiency virus (HIV) infection. In these groups, an increase in the incidence of sexually transmitted infections (STIs) is observed due to changes in sexual behavior after the initiation of antiretroviral therapy. Among these STIs, syphilis stands out as a significant public health problem worldwide…